Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 343, doi. 10.1007/s10072-024-07701-7
- By:
- Publication type:
- Article